Biotech Investment Analyst, Drug Asset & Company Assessment

Healthcare & Life Sciences • Independent Contractor • Remote • Weekly Payouts

Mercor is partnering with a biotech and pharma research team on expert human-evaluation work, creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a biotech investment analyst (specialist-fund background) for a paid pilot, with the potential to continue as the work scales.

Responsibilities

• Create and critique rubrics that analyze commercial drugs and drug-development programs

• Provide overall company and asset assessment, mechanism, clinical data, competitive position, and value drivers

• Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions

• Apply your assessment across the pilot's set of companies (~5, 10)

Requirements

• US-based biotech / healthcare investment analyst with a specialist-fund background

• Familiarity with biotech/pharma development programs

• Able to assess a drug asset and the company behind it end-to-end

• 5+ years evaluating biotech/pharma companies or assets

Engagement Details

• Duration: Approximately 10, 20 hours over a 1, 2 week pilot

• Remote, US-based

Why Participate

• Help improve expert AI evaluation of drugs and drug-development programs

• Recurring engagement for strong contributors

Details

• Pay: $120 to $200 per hour (part-time)
• Commitment: 15 hours per week • remote
• Eligible locations: United States
• Platform: Mercor (weekly payouts via Stripe or Wise)

Submit your application via the link below. Qualified candidates move through Mercor's short AI interview and selection process. Projects can be extended, shortened, or concluded early depending on needs and performance.